Arbutus Biopharma Corp Intellectual Property Contracts & Agreements

7 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Technology Transfer and Exclusive License Agreement, dated December 13, 2021, by and between the Company and Qilu Pharmaceutical Co., Ltd
License Agreements
Arbutus Biopharma Corp
Biotechnology
PA
2022
Third Amendment to Cross License Agreement, dated December 9, 2021, by and between Genevant Sciences GmbH and Arbutus Biopharma Corporation
License Agreements
Arbutus Biopharma Corp
Biotechnology
2021
Second Amendment to Cross License Agreement, dated June 27, 2018, by and among the Company, Genevant Sciences Ltd. And Genevant Sciences GmbH
License Agreements
Arbutus Biopharma Corp
Biotechnology
2020
First Amendment to Cross License Agreement, dated June 27, 2018, by and among the Company, Genevant Sciences Ltd. And Genevant Sciences GmbH
License Agreements
Arbutus Biopharma Corp
Biotechnology
2020
Cross License Agreement, dated April 11, 2018, by and between the Company and Genevant Sciences Ltd
License Agreements
Arbutus Biopharma Corp
Biotechnology
NY
2020
LICENSE AGREEMENT by and between ALEXION PHARMA HOLDING on the one hand, and ARBUTUS BIOPHARMA CORPORATION and PROTIVA BIOTHERAPEUTICS INC., on the other hand Dated as of March...
License Agreements
Arbutus Biopharma Corp
Biotechnology
NY
2017
License Agreement between OnCore Biopharma, Inc. and Cytos Biotechnology Ltd. dated December 30, 2014
License Agreements
Arbutus Biopharma Corp
Biotechnology
NY
2015